secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001295947-24-000015
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Q4 revenue down 2.9%; adj. EPS $1.02; $300M buyback; FY2025 EPS guidance $4.40-$4.46
--------------------------------------------------------------------------------

- Q4 revenue $277.0M (-2.9% ex-FX); non-GAAP adj. diluted EPS $1.02 vs $1.07 prior year.
- Full-year FY2024 revenue $1,125.4M (flat); GAAP diluted EPS $4.17; non-GAAP diluted EPS $4.21.
- Leverage ratio improved to 2.8x, below 3x target; net debt ~$1.1B.
- Board authorized new $300M share repurchase program; timing subject to market conditions.
- Initial FY2025 guidance: organic revenue growth ~1%, diluted EPS $4.40-$4.46, free cash flow $240M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000015/0001295947-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594724000015/pbh-20240514.htm
  HTML page:      https://secwatch.observer/filing/0001295947-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer